University of Pittsburgh Medical Center

• NCT07041281

  Collaborator, Phase 2, Recruiting, 204 people, 27 Jun 2025

• NCT06729996

  Collaborator, Phase 2, Recruiting, 50 people, 12 Dec 2024

• Improving Mobility After Revascularization in Peripheral Artery Disease

  Collaborator, Phase 3, Recruiting, 386 people, 13 Nov 2024

• NCT04469959

  Collaborator, Phase 2, Completed, 79 people, 14 Jul 2020

• NCT04221087

  Collaborator, Phase 4, Terminated, 3 people, 9 Jan 2020

• NCT03976973

  Collaborator, Phase 2, Status unknown, 62 people, 6 Jun 2019

• NCT03861767

  Collaborator, Phase 3, Terminated, 302 people, 4 Mar 2019

• NCT02938923

  Collaborator, Phase 3, Completed, 129 people, 19 Oct 2016

• NCT02735707

  Collaborator, Phase 3, Recruiting, 20,000 people, 13 Apr 2016

• NCT01825798

  Collaborator, Phase 3, Completed, 60 people, 8 Apr 2013

• ICARuS Post-operative Intraperitoneal Chemotherapy (EPIC) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) After Optimal Cytoreductive Surgery (CRS) for Neoplasms of the Appendix, Colon or Rectum With Isolated Peritoneal Metastasis

  Collaborator, Phase 2, Active, not recruiting, 292 people, 21 Mar 2013

• NCT01023477

  Collaborator, Phase 1/2, Completed, 12 people, 2 Dec 2009

• NCT00981435

  Collaborator, Phase 4, Completed, 97 people, 22 Sept 2009

Sources: clinicaltrials.gov

• ORIGINATION, DEVELOPMENT, AND VALIDATION OF THE SURGICAL PAUSE

  GSA 2024 abstract, 1 Jan 2025